Brennan Mulcahy (Chair), is the former CEO of Energy Saving Income Fund, Toronto, ON, a publicly-traded company with sales of over 700 million dollars last year. He has been involved in the deregulation of natural gas for 13 years. From January 1997 to July 1997, he served as a marketer for Consolidated Gas Limited (gas marketing company).
John Bell, PhD, CSO of Jennerex (see management section)
Robert Ingram is Vice Chairman of GlaxoSmithKline and former CEO and Chairman of GlaxoWellcome. Mr. Ingram is Chairman of the board of directors of OSI Pharmaceuticals, Inc., and also serves on other boards of directors including Allergan and Wachovia. In addition to his professional responsibilities, Mr. Ingram was asked by former President George H.W. Bush to form and chair the CEO Roundtable on Cancer. Mr. Ingram is active in several service organizations, including the, US Committee for UNICEF, Project HOPE, and the Arthur Ashe Institute for Urban Health.
David Kirn, MD, CEO and Co-Founder of Jennerex (see management section)
Martin Murphy, PhD is the Founding Chairman and CEO of AlphaMed Consulting, Inc. that provides strategic support to cancer centers, advocacy groups as well as the global pharmaceutical and biotechnology industry. He is Founding Executive Editor of the international, peer-reviewed journal, ěThe Oncologistî, which is read by more than 21,000 physicians. He founded and was the CEO of the Hipple Cancer Research Center where he was principal investigator of $12M of cancer research grant. He is also founding convener of the CEO Roundtable on Cancer, first-chaired by Robert A. Ingram at the request of former President George H.W. Bush.
Ken Newport, C.A., M.Acc. co-founded CroMedica International Inc., a contract research organization, in 1995. In 2002, CroMedica was sold to PRA International, one of the world's largest contract research organizations. From 2002 to 2005 Mr. Newport was Senior Vice President of PRA's International Business Development, following which he retired. Mr. Newport is a director of Zelos Therapeutics.
Herbert M. "Bob" Pinedo, MD, PhD is past president of ESMO (European Society for Medical Oncology) and of the VUMC Cancer Center, Amsterdam. Dr. Pinedo is an internationally renowned leader in translational cancer drug development. He was a former board member of EORTC and the Dutch Cancer Society and is currently an advisor to major pharmaceutical companies and is on the BOD of OSI Pharmaceuticals.
Calvin Stiller, CM, O. ONT, MD, F.R.C.P. (C) is chairman of the board and chief executive officer of Stilco Corporation and BioQuest Innovations Inc. Dr. Stiller has served as a director of NPS Pharmaceuticals Inc. since December 1999; he had served on the board of Allelix since April 1999. From 1996 to 2005, Dr. Stiller served as chairman and chief executive officer of Canadian Medical Discoveries Fund.
Ron Vered, P.Eng., is CEO of Arnon Corporation and past President of Ron Engineering and Construction (Eastern) Ltd., privately-owned real estate and construction companies based in Ottawa with international experience. Through the Vered Foundation, the Vered family has been active in and supportive of numerous causes including the United Jewish Appeal, the University of Ottawa Heart Institute, the University of Ottawa and the Ottawa Hospital. Mr. Vered is a Member of the Board of Trustees of S.C.O. Health Service and University of Ottawa Heart Institute.
Robert Donaldson, LL.B. (Board Secretary) is Chief Legal Counsel for Energy Saving Income Fund.